Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer

P. H. Su, Y. W. Lin, R. L. Huang, Y. P. Liao, H. Y. Lee, H. C. Wang, T. K. Chao, C. K. Chen, M. W Y Chan, T. Y. Chu, M. H. Yu, H. C. Lai

研究成果: 雜誌貢獻文章同行評審

48 引文 斯高帕斯(Scopus)

摘要

Epigenetic modifications are a driving force in carcinogenesis. However, their role in cancer metastasis remains poorly understood. The present study investigated the role of DNA methylation in the cervical cancer metastasis. Here, we report evidence of the overexpression of DNA methyltransferases 3B (DNMT3B) in invasive cervical cancer and of the inhibition of metastasis by DNMT3B interference. Using methyl-DNA immunoprecipitation coupled with microarray analysis, we found that the protein tyrosine phosphatase receptor type R (PTPRR) was silenced through DNMT3B-mediated methylation in the cervical cancer. PTPRR inhibited p44/42 MAPK signaling, the expression of the transcription factor AP1, human papillomavirus (HPV) oncogenes E6/E7 and DNMTs. The methylation status of PTPRR increased in cervical scrapings (n=358) in accordance with disease severity, especially in invasive cancer. Methylation of the PTPRR promoter has an important role in the metastasis and may be a biomarker of invasive cervical cancer.
原文英語
頁(從 - 到)15-26
頁數12
期刊Oncogene
32
發行號1
DOIs
出版狀態已發佈 - 一月 3 2013

ASJC Scopus subject areas

  • 分子生物學
  • 癌症研究
  • 遺傳學

指紋

深入研究「Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer」主題。共同形成了獨特的指紋。

引用此